dowoct15-300x144 Market Snapshot - Tuesday 10.15.19

As earnings season kicks off, the first companies to report are mostly those within the financial sector. Though the companies that reported today were a mixed bag, they helped start off the season on a strong note. 


JPMorgan Chase’s Q3 revenues topped analyst expectations and hitting a record level, its shares jumping 3%. United Health also topped expectations and raised its full-year guidance–shares of the Dow component gained 8.2%, it’s largest one-day gain in over a decade. Johnson & Johnson’s Q3 numbers were boosted by sales of its cancer drug and other prescription medications. J&J saw its stock climb 1.6%.


Although analysts expected to see a 3.2% decline in S&P 500 earnings from a year ago, it appears that corporate earnings started off much better than expected. The Dow surged 237.44 points, or 0.9%, closing above the key level of 27,000, the S&P 500 advanced 1% and the Nasdaq gained 1.2%. 


Of the 34 companies in the S&P 500 reporting today, 29 have reported figures above analyst earnings expectations. Today’s rally comes amid a backdrop of uncertainties in US-China trade negotiations and bearish analyst expectations. The season just started, but a strong start it is so far.

The risk of loss in the trading of stocks, options, futures, forex, foreign equities, and bonds can be substantial and is not suitable for all investors. Trading on margin or the use of leverage is not suitable for all investors and losses exceeding your initial deposit is possible. Supporting documentation is available upon request. Trading futures, options on futures, and FX involves substantial risk of loss and is not suitable for all investors. Carefully consider whether trading is suitable for you in light of your circumstances, knowledge, and financial resources and only risk capital should be used. Opinions, market data, and recommendations are subject to change at any time. The lower the margin used the higher the leverage and therefore increases your risk. Past performance is not necessarily indicative of future results.